Several leading UK universities are set to benefit from a £35m ($56m) investment by Cancer Research UK and the Engineering and Physical Sciences Research Council (EPSRC) into cancer imaging centres.
The centres, which provide invaluable feedback from patients as to how the body responds to cancer therapies, will enable researchers to develop treatments faster with a view to transferring the technologies more rapidly into real-world products.
The universities set to benefit are:
- Cambridge and Manchester (collaboration)
- Oxford University
- The Institute of Cancer Research, London
- University College London and King’s College London (collaboration).
Professor David Delpy, chief executive of the EPSRC, said: “This large investment is great news and builds upon our previous successful collaboration with Cancer Research UK. These centres will bring together many of the UK’s leading scientists, engineers and clinicians interested in all aspects of imaging research, speeding up advances in new technologies and ensuring these are applied rapidly for the benefit of patients.”
